Tonix Pharmaceuticals Showcases Positive Data on TNX-801 Vaccine Candidate at World Vaccine Congress
Tonix Pharmaceuticals presents promising results for TNX-801 vaccine at World Vaccine Congress, demonstrating efficacy against mpox and rabbitpox with lasting protection. Learn more about the company's innovative solutions.
This news matters as it highlights the potential of TNX-801 to address current and future mpox outbreaks, providing hope for effective vaccination strategies in global health emergencies.